David Paar, Associate Professor of Medicine, Director, HIV Care/TDCJ Correctional Managed Care

David Paar, Associate Professor of Medicine, Director, HIV Care/TDCJ Correctional Managed Care

Related

Adverse Events & Comorbidities

HIV-Associated Opportunistic Infections in Adults and Adolescents in the Era of HAART

David Paar, Associate Professor of Medicine, Director, HIV Care/TDCJ Correctional Managed Care; HIV Education Prison Project
8 Min Read

Table of Contents

Introduction An Overview of Opportunistic Infections Immune Reconstitution Tuberculosis Correctional-Specific Issues Relative to the Prevention and Treatment of OIs Self-Administered Keep On Person (KOP) vs. Directly Obse...

Adverse Events & Comorbidities

HIV-Associated Opportunistic Infections in Adults and Adolescents in the Era of HAART

David Paar, Associate Professor of Medicine, Director, HIV Care/TDCJ Correctional Managed Care; HIV Education Prison Project
8 Min Read

Table of Contents

Introduction An Overview of Opportunistic Infections Immune Reconstitution Tuberculosis Correctional-Specific Issues Relative to the Prevention and Treatment of OIs Self-Administered Keep On Person (KOP) vs. Directly Obse...

Adverse Events & Comorbidities

Hepatitis B Virus: Transmission, Prevention, Treatment and HIV Co-Infection

David Paar, Associate Professor of Medicine, Director, HIV Care/TDCJ Correctional Managed Care; Brown Medical School
9 Min Read

Hepatitis B Virus (HBV) infection is very common with over 350 million chronically infected people worldwide including 1.25 million in the United States. The incidence of acute HBV infection in the U.S. has declined from 450,000 new infections per ye...

Adverse Events & Comorbidities

Hepatitis B Virus: Transmission, Prevention, Treatment and HIV Co-Infection

David Paar, Associate Professor of Medicine, Director, HIV Care/TDCJ Correctional Managed Care; Brown Medical School
9 Min Read

Hepatitis B Virus (HBV) infection is very common with over 350 million chronically infected people worldwide including 1.25 million in the United States. The incidence of acute HBV infection in the U.S. has declined from 450,000 new infections per ye...